• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
2012 deep research report on china influenza vaccine industry
 

2012 deep research report on china influenza vaccine industry

on

  • 634 views

 

Statistics

Views

Total Views
634
Views on SlideShare
634
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    2012 deep research report on china influenza vaccine industry 2012 deep research report on china influenza vaccine industry Document Transcript

    • 2012 Deep Research Report on China Influenza Vaccine Industry2012 Deep Research Report on China Influenza Vaccine IndustryHard copy: 2200 USDElectronic copy (PDF):2200USDGlobal License: 4000USDPages: 144Tables and Figures: 155Published Date: May 9 2012Publisher: QY Research GroupContact: Mr. Zhang Dong 86-10-82945717 86-13811796901 sales@qyresearch.comSummary<2012 Deep Research Report on China Influenza Vaccine Industry > was a professional and depthresearch report on China Influenza Vaccine Industry. Firstly the report describes the backgroundknowledge of Influenza Vaccine, including Concepts Classification Manufacturing processtechnical parameters and equipments List etc; then statistics International and China 16Manufacturers Influenza Vaccine product 2009-2016 Capacity production cost price productionvalue profit margins and other relevant data, statistics these enterprises Influenza Vaccineproducts, Product Specifications, company background information, then summary statistics andanalysis the relevant data on these enterprises. The report got Global and China Influenza Vaccinecompanies production market share, China Influenza Vaccine demand supply and shortage, ChinaInfluenza Vaccine 2009-2016 production price cost profit production value profit margins,production market share by different Sources(China Domestic and Imported etc) . At the sametime, the report analyzed and discussed supply and demand changes in Influenza Vaccine marketand business development strategies, conduct a comprehensive analysis on China InfluenzaVaccine industry trends. Finally, the report also introduced 8Million Pieces/year Influenza Vaccineproject Feasibility analysis and related research conclusions. In a word, It was a depth researchreport on China Influenza Vaccine industry. And thanks to the support and assistance fromInfluenza Vaccine industry chain related experts and enterprises during QYResearch VaccineResearch Team survey and interview.QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 1(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine IndustryTable of ContentsChapter One Influenza Vaccine Industry Overview 11.1 Definition 11.2 Classification 21.2.1 Seasonal Influenza Vaccine 21.2.2 Type A H1N1 Influenza Vaccine 41.2.3 Two Type Influenza Vaccine Comparison 61.3 Vaccine Inoculation 71.4 Industry Chain Structure 91.5Influenza Vaccine Development Prospect 151.5.1 United States Overplus 151.5.2 Seek Competitive Differentiation New Technology Prevalence 171.5.3 Huge Market Demand in China 18Chapter Two Influenza Vaccine Manufacturing Technology and Process 192.1 Influenza Vaccine Manufacturing Technology Overview192.1.1 Embryo Culture Type A H1N1 Influenza Vaccine Manufacturing Process 202.1.2 Vero Cell Culture Inactivated Influenza Vaccine Manufacturing Process 232.2 Comparison of Two Procee Method 262.2.1 Embryo Culture Inactivated Influenza Vaccine Process Flow 262.2.2 Cell Culture Inactivated Influenza Vaccine Process Flow 272.2.3 Two Manufacturing Process Comparison 282.3 Influenza Vaccine Manufacturing Equipments List 302.4 Influenza Vaccine Manufacturing Process Today and Tomorrow 332.4.1 Influenza Vaccine Manufacturing Process Status 332.4.2 H1N1 Influenza Vaccine Manufacturing Process Problems 332.4.3 Influenza Vaccine New Manufacturing Technology 34Chapter Three Influenza Vaccine Production Supply Sales Demand Market Status and Forecast 383.1 Influenza Vaccine Productions Overview 383.2 Influenza Vaccine Demand Overview 493.4 Influenza Vaccine Cost Price Production Value Gross Margin53Chapter Four Influenza Vaccine Key Manufacturers 574.1 Hualan Bio (Henan) 574.2 Sinovac (Beijing) 654.3 Tianyuan Bio-pharma (Zhejiang) 734.4 Changsheng (Jilin Changchun) 774.5 Aleph Biomedical (Liaoning) 814.6 SIOBP (Shanghai) 874.7 CCBIO (Jilin Changchun) 91QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 2(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine Industry4.8 Lanzhou Institute of Biological Products (Qinghai)954.9 Tiantan Biological (Beijing) 994.10 Sanofi-pasteur (France) 1054.11 GSK (UK) 1094.12 Novartis (Switzerland) 1164.13 Abbott (US) 1224.14 Crucell (Holland) 1254.15 Tasly&Jenner (Tianjin) 1304.16 Neptunus Interlong (Shenzhen) 134Chapter Five China 8Million Pieces/Year Influenza Vaccine Project Investment FeasibilityAnalysis 1395.1 China 8Million Pieces/Year Influenza Vaccine Project Opportunities and Risks Analysis 1395.1.1 Opportunities 1395.1.2 Risks 1405.3 China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis1405.3.1 Project Overview 1415.3.2 Capacity 1415.3.3 Construction Standards 1415.3.3 Construction Period 1415.3.4 Project Schedule 1415.3.5 Investment Feasibility Analysis 142Chapter Six Influenza Vaccine Industry Research Conclusions 143Tables and FiguresTable Common Vaccines Classification 2Table Three Type Influenza Vaccine (Inactivated Whole Virus Vaccine Split Vaccine SubunitVaccine) Characteristic Comparison 4Table United States Approval Type A influenza H1N1 Vaccine Suppliers and ProductSpecifications List 5Table Europe Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 6Figure China First Type Vaccine and Second Type Vaccine Classification and Application 10Table First Type Vaccine and Second Type Vaccine Detail Market Analysis10Table 2009-2010 China First Type Vaccine and Second Type Vaccine Issue Number (10K Pieces)and Market Share 11Figure 2010 State-owned Private Foreign Enterprise Market Share in First Type Vaccine andSecond Type Vaccine 11Figure Influenza Vaccine Industry Chain Structure 12Figure Vaccine Cold Chain Circulation System 13Figure Vaccine Transportation Model 13QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 3(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine IndustryFigure First Type Vaccine Transportation Channel14Figure Second Type Vaccine Transportation Channel 14Figure Vaccine Transportation Steps and Process 15Figure 2009-2019 Global Influenza Vaccine Market Scale(100 Million USD) 16Figure 2007-2008 United States TOP5 Suppliers Influenza Vaccine Market Share 17Figure China Influenza Vaccine Inoculation Coverage Rate and Its Gap to International Goal 18Table Baxter Vero Cell Platform Background Information 23Figure Embryo Culture Inactivated Vaccine Manufacturing Process Flow 26Figure Cell Culture Inactivated Influenza Vaccine Manufacturing Process Flow 27Figure Two Influenza Vaccine Manufacturing Process Comparison 28Figure Influenza Vaccine Manufacturing Steps 30Figure Influenza Vaccine Detection Steps 31Table Influenza Vaccine Manufacturing Equipments List (38 Equipments) 32Figure Influenza Vaccine Production Periodic Table 33Figure Influenza Vaccine Production schedules 34Table Influenza Vaccine Development History 35Table Existing and R&D Influenza Vaccine Products List 35Figure Influenza Vaccine New Manufacturing Technology 37Table China 11 Manufacturers Influenza Vaccine Market Status List 38Table Selling Influenza Vaccine in China 5 Foreign Suppliers List 39Table 2009-2016 China 11 Manufacturers Influenza Vaccine Capacity and Total Capacity (10KPieces) List 40Table 2009-2016 China 11 Manufacturers Influenza Vaccine Capacity Market Share List 40Table 2009-2016 China 11 Manufacturers Influenza Vaccine Production and Total Production(10K Pieces) List 41Table 2009-2016 China 11 Manufacturers Influenza Vaccine Production Market Share List 42Table 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) and CapacityUtilization Rate 42Figure 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) and Growth Rate 43Figure 2011 China Key Manufacturers Influenza Vaccine Production Market Share (ChinaGovernment Approcal Data) 43Table 2009-2016 Global Key Suppliers Influenza Vaccine Capacity and Total Capacity (100Million Pieces) List43Table 2009-2016 Global Key Suppliers Influenza Vaccine Production and Total Production (100Million Pieces) List44Figure 2009-2016 Global Influenza Vaccine Capacity Production (100 Million Pieces) and GrowthRate 44Table 2009-2016 Global Influenza Vaccine Capacity Production (100 Million Pieces) andCapacity Utilization Rate 45Figure 2011 Global Key Suppliers Influenza Vaccine Production Market Share 45Table 2009-2016 Global Key Suppliers Influenza Vaccine China Sales (10K Pieces) List 45Figure 2011 China Imported Influenza Vaccine Market Share By Suppliers (China GovernmentApproval Data) 46QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 4(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine IndustryTable Global and China Key Suppliers Key Vaccine Products Sales in China 46Table 2007-2011 China Influenza Vaccine Approval Amount by Suppliers (10K Pieces) 47Figure 2011 China Influenza Vaccine Market Share by Splitting Vaccine and Subunit Vaccine(according China government approval amount) 48Table 2009-2016 China local Influenza Vaccine and Imported Influenza Vaccine Market ShareComparison 48Table 2001-2020 China Birth Rate and Population (10K) 49Figure China India Korea Japan etc 9 Countries Child Mortality (‰) 49Figure 1950-2050 China Working-age Population Proportion (%) 50Table 2000-2050 China Age Over 60 Population (100 Million) and Proportion (%) 50Figure 2010-2050 China Age Over 60 Over 65 Over 80 Population Proportion 51Table 2001-2015 China Per Capita GDP (USD) and Growth Rate 51Figure 2009-2016 China Influenza Vaccine Supply Demand (10K Pieces) and Growth Rate 52Figure China Japan France etc 9 Countries Age Over 65 Population Influenza Vaccine InoculationCoverage Rate52Table 2009-2016 China Influenza Vaccine Supply Demand and Shortage (10K Pieces) 53Table 2011 Hangzhou Disease Control and Prevention Center 33 Type Influenza Vaccine ProductsPurchase and Selling Price (RMB/Piece) 53Table 2011 China and Imported Influenza Vaccine Capacity Production (10K Pieces) Price CostProfit (RMB/Piece) Gross Margin List 56Table 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) Price Cost Gross(RMB/Piece) Production Value (10K RMB) Gross Margin List 56Table Hualan Bio Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 57Figure Hualan Bio Vaccine Factory Picture 58Figure Hualan Bio Influenza Virus Split Vaccine (Childhood Type) 59Figure Hualan Bio Influenza Virus Split Vaccine (Adult Type) 61Figure Hualan Bio Type A H1N1 Influenza Virus Split Vaccine 62Table 2009-2016 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces)Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 64Figure 2009-2016 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces)and Growth Rate 64Table Sinovac Biotech Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 65Table Sinovac Biotech Vaccine Plant Picture 66Table Sinovac Biotech Development History Time Table 66Figure Sinovac Biotech Influenza Virus Split Vaccine-Anrlaifu 67Figure Sinovac Biotech Pandemic Influenza Virus Inactivated Vaccine - Panrlaifu 69Figure Sinovac Biotech Type A H1N1 Influenza Virus Split Vaccine - Panrlaifu.1 71Table 2009-2016 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces)Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 72Figure 2009-2016 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10KPieces) and Growth Rate73Table Tianyuan Bio-pharma Company Information Table(Products Development History LocationQYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 5(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine IndustryBackground Contact Information etc 14 Items) 73Figure Tianyuan Bio-pharma Influenza Vaccine Products List 75Figure Tianyuan Bio-pharma Influenza Virus Split Vaccine - Yuganning 75Table 2009-2016 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10KPieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 76Figure 2009-2016 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10KPieces) and Growth Rate77Table Changsheng Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 77Figure Changsheng Influenza Virus Split Vaccine - Wanxin 79Figure Changsheng Type A H1N1 Influenza Virus Split Vaccine 80Table 2009-2016 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces)Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 80Figure 2009-2016 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces)and Growth Rate 81Table Aleph Biomedical Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 81Table Aleph Biomedical Contact Information List82Figure Aleph Biomedical Influenza Vaccine Manufacturing Workshop 83Figure Aleph Biomedical Influenza Virus Split Vaccine(Adult Type) 84Figure Aleph Biomedical Influenza Virus Split Vaccine (Childhood Type) 85Table 2009-2016 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10KPieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 86Figure 2009-2016 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10KPieces) and Growth Rate86Table SIOBP (Shanghai Institute of Biological Products) Company Information Table(ProductsDevelopment History Location Background Contact Information etc 14 Items) 87Figure CNBG and Six Institutes Equity Relationship 88Figure SIOBP Influenza Virus Split Vaccine 89Figure SIOBP Type A H1N1 Influenza Virus Split Vaccine 89Table 2009-2016 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) PriceCost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 90Figure 2009-2016 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) andGrowth Rate 91Table CCBIO(Changchun Institute of Biological Products) Company Information Table(ProductsDevelopment History Location Background Contact Information etc 14 Items) 91Figure CCBIO Influenza Split Vaccine - Shipulir 93Figure CCBIO Factory Workshop Picture 93Table 2009-2016 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) PriceCost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 94Figure 2009-2016 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) andGrowth Rate 95Table Lanzhou Institute of Biological Products Company Information Table(ProductsDevelopment History Location Background Contact Information etc 14 Items) 95QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 6(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine IndustryFigure Lanzhou Institute of Biological Products Factory Picture 97Figure Lanzhou Institute of Biological Products Trivalent Influenza Split Vaccine 97Table 2009-2016 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine CapacityProduction (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) GrossMargin List 97Figure 2009-2016 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine CapacityProduction (10K Pieces) and Growth Rate 98Table Tiantan Biological Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 99Figure Tiantan Biological Control Shares of Sinopharm 101Figure Tiantan Biological and Related Control Subsidiaries Relationship 101Figure Tiantan Biological Factory Picture 102Figure Tiantan Biological Beijing Yizhuang Vaccine Plants Picture 102Figure Tiantan Biological Type A H1N1 Influenza Virus Split Vaccine 103Figure Tiantan Biological Influenza Virus Split Vaccine 103Table 2009-2016 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10KPieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 104Figure 2009-2016 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10KPieces) and Growth Rate105Table Sanofi-pasteur Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 105Figure Sanofi-pasteur China Pharmaceutical Factories Distribution 107Figure Influenza Virus Split Vaccine-Fanrling 107Table 2009-2016 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100MillionPieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB)Gross Margin List 108Figure 2009-2016 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100MillionPieces) and Growth Rate109Table GSK Company Information Table(Products Development History Location BackgroundContact Information etc 14 Items) 110Figure GSK Shenzhen Influenza Vaccine Workshop Pictures 113Figure GSK Influenza Split Vaccine - Fululishi 114Table 2009-2016 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces)China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) GrossMargin List 114Figure 2009-2016 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) andGrowth Rate 115Table Novartis Company Information Table(Products Development History Location BackgroundContact Information etc 14 Items) 116Figure Novartis Subunit Influenza Vaccine - Agrippal 119Figure Novartis Aged Population Special Use Influenza Vaccine - Fluad 120Table 2009-2016 Novartis Influenza Virus Subunit Vaccine Capacity Production (100MillionPieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB)Gross Margin List 121QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 7(8 Total)
    • 2012 Deep Research Report on China Influenza Vaccine IndustryFigure 2009-2016 Novartis Influenza Virus Subunit Vaccine Capacity Production (100MillionPieces) and Growth Rate121Table Abbott Company Information Table(Products Development History Location BackgroundContact Information etc 14 Items) 122Figure Abbott Influenza Subunit Vaccine - Influvac 124Table 2009-2016 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces)China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) GrossMargin List 124Figure 2009-2016 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) andGrowth Rate 125Table Crucell Company Information Table(Products Development History Location BackgroundContact Information etc 14 Items) 126Table Crucell Selling Vaccines and R&D Projects List 128Table Crucell V Type Virion Adjuvant Influenza Vaccine (Subunit ) - Inflexal 129Table 2009-2016 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces)China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) GrossMargin List 129Table 2009-2016 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) andGrowth Rate 130Table Tasly&Jenner Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 130Figure Tasly&Jenner Factory Pictures 132Figure Tasly&Jenner Subunit Influenza Virus Split Vaccine-Fuluoke® 132Table 2009-2016 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10KPieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 133Table 2009-2016 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10KPieces) and Growth Rate134Table Neptunus Interlong Company Information Table(Products Development History LocationBackground Contact Information etc 14 Items) 134Figure Neptunus Interlong Vaccine Factory Picture 136Figure Neptunus Interlong Vaccine Workshop Picture 136Figure Neptunus Interlong Influenza Subunit Vaccine Package 137Table 2009-2016 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10KPieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 138Table 2009-2016 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10KPieces) and Growth Rate138Table China 8Million Pieces/Year Influenza Vaccine Project Investments List 140Table China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 142QYResearch Mr. Zhangdong sales@qyresearch.com 13811796901 8610-82945717 8(8 Total)